Buscar resultados de ensayos clínicos
Lymphoma, Primary Cutaneous Anaplastic Large Cell - 8 Studies Found
Estado | Estudiar |
Withdrawn |
Nombre del estudio: MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma Condición: Lymphoma, Large-Cell Fecha: 2006-03-01 Intervenciones: Drug: MDX-060 |
Completed |
Nombre del estudio: Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma Condición: Large Cell Lymphoma Fecha: 2004-12-10 Intervenciones: Drug: SGN-30 |
Active, not recruiting |
Nombre del estudio: A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell Lymphoma Condición:
|
Completed |
Nombre del estudio: Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma Condición:
|
Active, not recruiting |
Nombre del estudio: SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) Condición:
|
Recruiting |
Nombre del estudio: Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma Condición:
Intervenciones: |
Recruiting |
Nombre del estudio: Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency Condición:
|
Recruiting |
Nombre del estudio: Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides Condición:
Intervenciones: Genetic: Genetically modified T cells # 1138 |